A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy and tolerability of a fixed dose of BH-200 (250 mg BID) i...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
DepressionDrug
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What the source confirms
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
What should you check before joining?
Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
324
Sponsor
HMNC Holding GmbH
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Bulgaria, Estonia, Germany, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2022-002757-26
Official title
A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy and tolerability of a fixed dose of BH-200 (250 mg BID) i...
Check recruitment and locations
EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Bulgaria · 13 sites
Center For Mental Health Prof. Dr. Ivan Temkov Burgas EOOD — Center For Mental Health Prof. Dr. Ivan Temkov Burgas EOOD
Burgas
Country status: Not recruiting
Multiprofile Hospital For Active Treatment Dr. Hristo Stambolski EOOD — Department of Psychiatry
Kazanlik
Country status: Not recruiting
University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD — First Clinic of Psychiatry
Pleven
Country status: Not recruiting
Ambulatory For Group Practice For Specialized Psychiatric Help Philipopolis Ltd. — Ambulatory For Group Practice For Specialized Psychiatric Help Philipopolis Ltd.
Plovdiv
Country status: Not recruiting
Center For Mental Health Ruse EOOD — Center For Mental Health Ruse EOOD
Ruse
Country status: Not recruiting
Medical Center Hera EOOD — Medical Center Hera EOOD
Sofiya
Country status: Not recruiting
Medical Center Hera EOOD — Medical Center Hera EOOD
Sofiya
Country status: Not recruiting
Medical Center Intermedica Ltd. — Medical Center Intermedica Ltd.
Sofiya
Country status: Not recruiting
Medical Center Saint Naum EOOD — Medical Center Saint Naum EOOD
Sofiya
Country status: Not recruiting
Diagnostics-Consultancy Center Mladost M Varna OOD — Diagnostics-Consultancy Center Mladost M Varna OOD
Varna
Country status: Not recruiting
Diagnostics-Consultancy Center Mladost M Varna OOD — Diagnostics-Consultancy Center Mladost M Varna OOD
Varna
Country status: Not recruiting
Med Centre Medical Plus — II Psychiatric Clinic
Varna
Country status: Not recruiting
Center For Mental Health Vratsa EOOD — Center For Mental Health Vratsa EOOD
Spectrum Centrum Psychiatrii Agata MAKAREWICZ Specjalistyczny Gabinet Psychiatryczny — -
Lublin
Country status: Not recruiting
Centrum Medyczne Hcp Sp. z o.o. — -
Poznan
Country status: Not recruiting
Filip Rybakowski Specjalistyczna Praktyka Lekarska — -
Poznań
Country status: Not recruiting
Syntonia Sp. z o.o. — -
Pruszcz Gdanski
Country status: Not recruiting
Slovakia · 5 sites
Penta Hospitals SK a.s. — Psychiatricka ambulancia všeobecná II
Rimavska Sobota
Country status: Not recruiting
PsychoLine s.r.o. — Psychiatricka ambulancia
Rimavska Sobota
Country status: Not recruiting
Mentum s.r.o. — Psychiatricka ambulancia
Stare Mesto
Country status: Not recruiting
Crystal Comfort s.r.o. — Centrum pre psychické funkcie
Vranov Nad Toplou
Country status: Not recruiting
Bona Medic s.r.o. — Psychiatricka ambulancia
Zlate Moravce
Country status: Not recruiting
Spain · 5 sites
Hospital Universitario Fundacion Alcorcon — Departamento de Psiquiatria. Sala 6. Puerta 19.
Alcorcon
Country status: Not recruiting
Hestia Palau S.L. — -
Barcelona
Country status: Not recruiting
Hospital Clinic De Barcelona — -
Barcelona
Country status: Not recruiting
Hospital Universitari Vall D Hebron — Antiguo Efidicio de Enfermeria. Planta 5ª - Servicio de Psiquiatria.
Barcelona
Country status: Not recruiting
University Hospital Son Espases — -
Palma
Country status: Not recruiting
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: EUCTR 2022-002757-26. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What does the official source confirm?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Is this study recruiting?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
How can I check the participation requirements?
Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
